cbdMD, Inc.
YCBD · AMEX
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $5,158 | $143 | $13,656 | $16,215 |
| - Cash | $1,060 | $1,765 | $1,970 | $2,453 |
| + Debt | $963 | $1,145 | $1,625 | $1,270 |
| Enterprise Value | $5,061 | -$477 | $13,311 | $15,033 |
| Revenue | $4,607 | $4,749 | $5,113 | $4,556 |
| % Growth | -3% | -7.1% | 12.2% | – |
| Gross Profit | $2,831 | $2,959 | $3,401 | $2,454 |
| % Margin | 61.5% | 62.3% | 66.5% | 53.9% |
| EBITDA | -$456 | $95 | $253 | $276 |
| % Margin | -9.9% | 2% | 4.9% | 6.1% |
| Net Income | -$895 | -$1,481 | $15 | -$153 |
| % Margin | -19.4% | -31.2% | 0.3% | -3.4% |
| EPS Diluted | -0.21 | -1.9 | -0.22 | 1.52 |
| % Growth | 88.9% | -763.6% | -114.5% | – |
| Operating Cash Flow | -$704 | -$507,108 | -$318 | $167 |
| Capital Expenditures | -$1 | -$179,729 | -$164 | -$110 |
| Free Cash Flow | -$706 | -$686,837 | -$482 | $57 |